Fundraising FoxAdjutec Pharma
2 known investors
Find your way into Adjutec Pharma
Sign up to see every warm intro you have to Adjutec Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Adjutec Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AdjuTec Pharma develops antibacterial technology targeting healthcare-associated infections, with a focus on Gram-negative bacterial infections in hospital and intensive-care settings. Its lead candidate, APC148, addresses the β-lactam and β-lactamase inhibitor market.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Adjutec Pharma do?
- AdjuTec Pharma develops antibacterial technology targeting healthcare-associated infections, with a focus on Gram-negative bacterial infections in hospital and intensive-care settings. Its lead candidate, APC148, addresses the β-lactam and β-lactamase inhibitor market.
- Who founded Adjutec Pharma?
- Adjutec Pharma was founded by Pål Rongved.
- Who are Adjutec Pharma's investors?
- Adjutec Pharma's investors include Farvatn Venture, Planet 9 Capital.